TITUSVILLE, N.J., Oct. 2, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking a new indication for SPRAVATO® (esketamine) CIII nasal spray for the rapid reduction of depressive symptoms in adult patients with major

ALHAMBRA, Calif., Oct. 2, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that it has entered into a new Management Services Agreement ("MSA"), effective January 1, 2020, to provide management services, via a subcontract

MENLO PARK, Calif., Oct. 2, 2019 /PRNewswire/ -- Adicet Bio, Inc., a biopharmaceutical company focused on the development of allogeneic cell therapies for cancer using innovative gamma delta T cells, announced today the completion of an $80 million Series B financing.

FREDERICK, Md., Oct. 2, 2019 /PRNewswire/ -- An exploratory study, conducted by NetNoggin®, revealed that among those impacted by Alzheimer's, hope of finding a cure is deflating due to recent Alzheimer's clinical trial failures in the past few years:

SAN CLEMENTE, Calif., Oct. 2, 2019 /PRNewswire/ -- Epica International, Inc. (Epica), received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SeeFactorCT3™ Imaging Platform. SeeFactorCT3™ consists of 3 integrated imaging systems: CT, Fluoroscopy and Digital Radiography; a detachable patient table/chair, and sterile drape for i

WASHINGTON, Oct. 2, 2019 /PRNewswire/ -- Today the Blue Cross and Blue Shield Federal Employee Program® (FEP®), announced 2020 benefits with innovative health tools, cost transparency solutions and quality benefits for eligible participants in the Federal Employees Health Benefits (FEHB) Program and the Federal Employees Dental and Visi

NEW YORK, Oct. 2, 2019 /PRNewswire/ -- Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds.  Published online in

WASHINGTON, Oct. 2, 2019 /PRNewswire/ -- The National Association for Behavioral Healthcare (NABH) Board of Trustees has appointed Shawn Coughlin as its president and CEO beginning in January 2020.Coughlin succeeds Mark Covall, who is retiring after more than 35 years

JACKSONVILLE, Fla., Oct. 2, 2019 /PRNewswire/ -- Availity, the nation's largest real-time health information network, named Frank J. Manzella its new Senior Vice Presi

MINNEAPOLIS, Oct. 2, 2019 /PRNewswire/ -- With autism spectrum disorder (ASD) on the rise — the CDC states about 1 in 59 children has ASD — there is a growing need for services in Minnesota. As the state's largest and most experienced provider of autism and early childhood mental health services, Fraser is responding to t